Review



fluorogenic proteasome substrate iii suc-leu-leu-val-tyr-amc (suc-llvy-amc  (Enzo Biochem)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Enzo Biochem fluorogenic proteasome substrate iii suc-leu-leu-val-tyr-amc (suc-llvy-amc
    Left panel: P4.R5 cells were pretreated with MG-132 (25 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM <t>Suc-LLVY-AMC</t> (with or without 25 μM MG-132) immediately or after a 2- or 5-hour incubation. Right panel: P4.R5 cells were pretreated with bortezomib (1 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 1 μM bortezomib) immediately or after a 2- or 5-hour incubation. Measurements were taken every 3 minutes in a fluorometer; the cells were maintained at 37° C. Each point represents the average of 3 measurements (C.V. < 1% in all cases). “LLVY” is suc-LLVY-AMC.
    Fluorogenic Proteasome Substrate Iii Suc Leu Leu Val Tyr Amc (Suc Llvy Amc, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic proteasome substrate iii suc-leu-leu-val-tyr-amc (suc-llvy-amc/product/Enzo Biochem
    Average 90 stars, based on 1 article reviews
    fluorogenic proteasome substrate iii suc-leu-leu-val-tyr-amc (suc-llvy-amc - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Evidence Against a Direct Antiviral Activity of the Proteasome during the Early Steps of HIV-1 Replication"

    Article Title: Evidence Against a Direct Antiviral Activity of the Proteasome during the Early Steps of HIV-1 Replication

    Journal:

    doi: 10.1016/j.virol.2007.01.018

    Left panel: P4.R5 cells were pretreated with MG-132 (25 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 25 μM MG-132) immediately or after a 2- or 5-hour incubation. Right panel: P4.R5 cells were pretreated with bortezomib (1 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 1 μM bortezomib) immediately or after a 2- or 5-hour incubation. Measurements were taken every 3 minutes in a fluorometer; the cells were maintained at 37° C. Each point represents the average of 3 measurements (C.V. < 1% in all cases). “LLVY” is suc-LLVY-AMC.
    Figure Legend Snippet: Left panel: P4.R5 cells were pretreated with MG-132 (25 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 25 μM MG-132) immediately or after a 2- or 5-hour incubation. Right panel: P4.R5 cells were pretreated with bortezomib (1 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 1 μM bortezomib) immediately or after a 2- or 5-hour incubation. Measurements were taken every 3 minutes in a fluorometer; the cells were maintained at 37° C. Each point represents the average of 3 measurements (C.V. < 1% in all cases). “LLVY” is suc-LLVY-AMC.

    Techniques Used: Incubation



    Similar Products

    fluorogenic proteasome substrate iii suc-llvy-amc  (Millipore)
    90
    Millipore fluorogenic proteasome substrate iii suc-llvy-amc
    Fluorogenic Proteasome Substrate Iii Suc Llvy Amc, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic proteasome substrate iii suc-llvy-amc/product/Millipore
    Average 90 stars, based on 1 article reviews
    fluorogenic proteasome substrate iii suc-llvy-amc - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    fluorogenic proteasome substrate iii suc-leu-leu-val-tyr-amc (suc-llvy-amc  (Enzo Biochem)
    90
    Enzo Biochem fluorogenic proteasome substrate iii suc-leu-leu-val-tyr-amc (suc-llvy-amc
    Left panel: P4.R5 cells were pretreated with MG-132 (25 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM <t>Suc-LLVY-AMC</t> (with or without 25 μM MG-132) immediately or after a 2- or 5-hour incubation. Right panel: P4.R5 cells were pretreated with bortezomib (1 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 1 μM bortezomib) immediately or after a 2- or 5-hour incubation. Measurements were taken every 3 minutes in a fluorometer; the cells were maintained at 37° C. Each point represents the average of 3 measurements (C.V. < 1% in all cases). “LLVY” is suc-LLVY-AMC.
    Fluorogenic Proteasome Substrate Iii Suc Leu Leu Val Tyr Amc (Suc Llvy Amc, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic proteasome substrate iii suc-leu-leu-val-tyr-amc (suc-llvy-amc/product/Enzo Biochem
    Average 90 stars, based on 1 article reviews
    fluorogenic proteasome substrate iii suc-leu-leu-val-tyr-amc (suc-llvy-amc - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    fluorogenic proteasome substrate iii (suc-llvy-amc  (Enzo Biochem)
    90
    Enzo Biochem fluorogenic proteasome substrate iii (suc-llvy-amc
    Left panel: P4.R5 cells were pretreated with MG-132 (25 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM <t>Suc-LLVY-AMC</t> (with or without 25 μM MG-132) immediately or after a 2- or 5-hour incubation. Right panel: P4.R5 cells were pretreated with bortezomib (1 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 1 μM bortezomib) immediately or after a 2- or 5-hour incubation. Measurements were taken every 3 minutes in a fluorometer; the cells were maintained at 37° C. Each point represents the average of 3 measurements (C.V. < 1% in all cases). “LLVY” is suc-LLVY-AMC.
    Fluorogenic Proteasome Substrate Iii (Suc Llvy Amc, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic proteasome substrate iii (suc-llvy-amc/product/Enzo Biochem
    Average 90 stars, based on 1 article reviews
    fluorogenic proteasome substrate iii (suc-llvy-amc - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Left panel: P4.R5 cells were pretreated with MG-132 (25 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 25 μM MG-132) immediately or after a 2- or 5-hour incubation. Right panel: P4.R5 cells were pretreated with bortezomib (1 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 1 μM bortezomib) immediately or after a 2- or 5-hour incubation. Measurements were taken every 3 minutes in a fluorometer; the cells were maintained at 37° C. Each point represents the average of 3 measurements (C.V. < 1% in all cases). “LLVY” is suc-LLVY-AMC.

    Journal:

    Article Title: Evidence Against a Direct Antiviral Activity of the Proteasome during the Early Steps of HIV-1 Replication

    doi: 10.1016/j.virol.2007.01.018

    Figure Lengend Snippet: Left panel: P4.R5 cells were pretreated with MG-132 (25 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 25 μM MG-132) immediately or after a 2- or 5-hour incubation. Right panel: P4.R5 cells were pretreated with bortezomib (1 μM) or nothing for 5 hours. The cells were then washed and exposed to 150 μM Suc-LLVY-AMC (with or without 1 μM bortezomib) immediately or after a 2- or 5-hour incubation. Measurements were taken every 3 minutes in a fluorometer; the cells were maintained at 37° C. Each point represents the average of 3 measurements (C.V. < 1% in all cases). “LLVY” is suc-LLVY-AMC.

    Article Snippet: Fluorogenic Proteasome Substrate III Suc-Leu-Leu-Val-Tyr-AMC (Suc-LLVY-AMC) was purchased from Axxora (#BST-S-280) and resuspended in DMSO.

    Techniques: Incubation